Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2Anus Neoplasms 2Anal Canal Carcinoma 2Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Squamous Cell Carcinoma of Head and Neck 1Pancreatic Adenocarcinoma 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Metastatic Small Intestinal Adenocarcinoma 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Hepatoblastoma 1Fibrolamellar hepatocellular carcinoma 1Colorectal Neoplasms 1Carcinoma 1Adenocarcinoma Of Esophagus 1

Interventions

Fluorouracil 9Radiotherapy 8Cisplatin 7Paclitaxel 5Oxaliplatin 5Leucovorin 4Irinotecan 4Cetuximab 3Surgical Procedures, Operative 2Filgrastim 2Docetaxel 2uridine triacetate 1pegylated granulocyte colony-stimulating factor, human 1pegfilgrastim 1dehydroftorafur 1Sorafenib 1Radiation 1Polymerase Chain Reaction 1Platinum 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Folfox protocol 1Drug Therapy 1Chemotherapy, Adjuvant 1Capecitabine 1Amplified Fragment Length Polymorphism Analysis 1AMG 337 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Adenocarcinoma Of Esophagus × dehydroftorafur × Clear all
NCT04248452 2026-05-05

Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
314 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡